Wholesale only — for distributors, hospitals, labs, pharmacies, radiology centers & vet clinics
CT Contrast Media (Iohexol) – 300 mgI/mL / 100 mL – GE Healthcare

CT Contrast Media (Iohexol) – 300 mgI/mL / 100 mL – GE Healthcare

On request

This product is quoted on request — ask for a quote and our sales team replies with today's price.

Add more products to the same order for an extra discount

  • Instant replacement for damaged goods — min. 12-month shelf life
  • Delivery to Cairo & Giza within business days

CT Contrast Media (Iohexol) – 300 mgI/mL / 100 mL – GE Healthcare

Omnipaque 300 is a non-ionic iodinated contrast medium (iohexol 300 mgI/mL) supplied in a 100 mL bottle for intravenous, intra-arterial, or intrathecal injection. Each mL contains 647 mg iohexol, providing 300 mg organically bound iodine. Used in CT scanning, angiography, urography, and related diagnostic imaging procedures. Supplied by GE Healthcare; store protected from light per manufacturer instructions.

Specifications

Size
300 mgI/mL – 100 mL
Brand
GE Healthcare (Omnipaque)
Form
Solution for injection
Type
Non-ionic iodinated contrast medium
Generic name
Iohexol
Concentration
300 mgI/mL (647 mg iohexol/mL)
Volume per vial
100 mL
Inactive ingredients
Edetate calcium disodium 0.1 mg/mL, Tromethamine 1.21 mg/mL
Route of administration
IV, intra-arterial, intrathecal, oral/rectal (per indication)

Questions & answers

What is the difference between Omnipaque 300 and Omnipaque 350?

The difference is iodine concentration: Omnipaque 300 provides 300 mgI/mL and is suitable for most CT applications, while Omnipaque 350 offers a higher concentration preferred for detailed vascular and interventional imaging.

How many bottles are in one case?

Each case contains 10 bottles of 100 mL each.

Is Omnipaque 300 safe for patients with iodine allergy?

Patients with known iodine or contrast media hypersensitivity should be assessed by a physician prior to use. Pre-medication or contraindication may apply; always follow clinical protocols.

What are the approved routes of administration for Omnipaque 300?

Omnipaque 300 can be administered intravenously or intra-arterially for CT and angiography, and orally or rectally for GI tract imaging, per approved clinical protocols.

Related products

Message us on WhatsApp